{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:17:09Z","timestamp":1787797029289,"version":"build-2784847793"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06127-7","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:05:13Z","timestamp":1781705113000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A pragmatic clinical risk score for adverse outcomes in hypertrophic cardiomyopathy using routine laboratory and bedside variables"],"prefix":"10.1186","volume":"26","author":[{"given":"Zi-Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"23","key":"6127_CR1","doi-asserted-by":"publisher","first-page":"e1239","DOI":"10.1161\/CIR.0000000000001250","volume":"149","author":"SR Ommen","year":"2024","unstructured":"Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA, Day SM, Dearani JA, Epps KC, Evanovich L, Ferrari VA, Joglar JA, Khan SS, Kim JJ, Kittleson MM, Krittanawong C, Martinez MW, Mital S, Naidu SS, Saberi S, Semsarian C, Times S, Waldman CB. Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2024;149(23):e1239\u2013311. 2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR Guideline for the.","journal-title":"Circulation"},{"issue":"19","key":"6127_CR2","doi-asserted-by":"publisher","first-page":"e036663","DOI":"10.1161\/JAHA.124.036663","volume":"13","author":"QF Chen","year":"2024","unstructured":"Chen QF, Zou J, Katsouras CS, You S, Zhou J, Ge HB, Liu C, Zhou X, Ni C, Peng Y, Hong C, Lin WH, Zhou XD. Clinical Characteristics and Outcomes in Patients With Apical and Nonapical Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2024;13(19):e036663.","journal-title":"J Am Heart Assoc"},{"key":"6127_CR3","doi-asserted-by":"publisher","unstructured":"Santoro F, Mango F, Mallardi A, D\u2019Alessandro D, Casavecchia G, Gravina M, Correale M, Brunetti ND. Arrhythmic risk stratification among patients with hypertrophic cardiomyopathy. J Clin Med. 2023;12(10):3397. https:\/\/doi.org\/10.3390\/jcm12103397.","DOI":"10.3390\/jcm12103397"},{"issue":"4","key":"6127_CR4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.recesp.2023.11.011","volume":"77","author":"Comments on","year":"2024","unstructured":"Comments on. the 2023 ESC guidelines for the management of cardiomyopathies. Rev Esp Cardiol (Engl Ed). 2024;77(4):285\u20139.","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"1","key":"6127_CR5","doi-asserted-by":"publisher","first-page":"94","DOI":"10.5334\/gh.1380","volume":"19","author":"M Oliveira Antunes","year":"2024","unstructured":"Oliveira Antunes M, Fernandes F, Arteaga-Fernandez E, Alvarez Ramires FJ, Machado Correia V, Novaes Cardoso J, Romero CE, Sousa HM, Soliani MT, Dal Piaz MRR, Rodrigues Gandarella AD, Rocha Teixeira RG, Mady C, Assis Moura Tavares C, Guimar\u00e3es PO, Junior VM. Validation of ACC\/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study. Glob Heart. 2024;19(1):94.","journal-title":"Glob Heart"},{"key":"6127_CR6","doi-asserted-by":"publisher","first-page":"10334","DOI":"10.3389\/ebm.2024.10334","volume":"249","author":"OS Chumakova","year":"2024","unstructured":"Chumakova OS, Mershina EA. Circulating microRNA as promising biomarkers in hypertrophic cardiomyopathy: can advanced cardiac magnetic resonance unlock new insights in research? Exp Biol Med (Maywood). 2024;249:10334.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"5","key":"6127_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.jcmg.2023.07.005","volume":"17","author":"A Kiaos","year":"2024","unstructured":"Kiaos A, Daskalopoulos GN, Kamperidis V, Ziakas A, Efthimiadis G, Karamitsos TD. Quantitative Late Gadolinium Enhancement Cardiac Magnetic Resonance and Sudden Death in Hypertrophic Cardiomyopathy: A Meta-Analysis. JACC Cardiovasc Imaging. 2024;17(5):489\u201397.","journal-title":"JACC Cardiovasc Imaging"},{"issue":"5","key":"6127_CR8","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1002\/ehf2.14073","volume":"9","author":"M Jansen","year":"2022","unstructured":"Jansen M, Alg\u00fcl S, Bosman LP, Michels M, van der Velden J, de Boer RA, van Tintelen JP, Asselbergs FW, Baas AF. Blood-based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta-analysis. ESC Heart Fail. 2022;9(5):3418\u201334.","journal-title":"ESC Heart Fail"},{"issue":"1","key":"6127_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40001-024-02222-7","volume":"30","author":"M Zhang","year":"2025","unstructured":"Zhang M, Gao W, Cui X, Han X, Xu Y, Zhou J, Ge J. High-sensitive cardiac troponin T and NT-proBNP are associated with the left ventricular apical thickness in apical hypertrophic cardiomyopathy. Eur J Med Res. 2025;30(1):50.","journal-title":"Eur J Med Res"},{"key":"6127_CR10","doi-asserted-by":"publisher","unstructured":"Chevalier C, Wendner M, Suling A, Cavus E, Muellerleile K, Lund G, Kirchhof P, Patten M. Association of NT-proBNP and hs-cTnT with imaging markers of diastolic dysfunction and focal myocardial fibrosis in hypertrophic cardiomyopathy. Life (Basel). 2022;12(8):1241. https:\/\/doi.org\/10.3390\/life12081241.","DOI":"10.3390\/life12081241"},{"issue":"32","key":"6127_CR11","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1093\/eurheartj\/eht070","volume":"34","author":"CJ Coats","year":"2013","unstructured":"Coats CJ, Gallagher MJ, Foley M, O\u2019Mahony C, Critoph C, Gimeno J, Dawnay A, McKenna WJ, Elliott PM. Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathy. Eur Heart J. 2013;34(32):2529\u201337.","journal-title":"Eur Heart J"},{"issue":"5","key":"6127_CR12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00392-023-02310-4","volume":"113","author":"A Amr","year":"2024","unstructured":"Amr A, Koelemen J, Reich C, Sedaghat-Hamedani F, Kayvanpour E, Haas J, Frese K, Lehmann D, Katus HA, Frey N, Meder B. Improving sudden cardiac death risk stratification in hypertrophic cardiomyopathy using established clinical variables and genetic information. Clin Res Cardiol. 2024;113(5):728\u201336.","journal-title":"Clin Res Cardiol"},{"key":"6127_CR13","doi-asserted-by":"publisher","first-page":"971453","DOI":"10.1155\/2015\/971453","volume":"2015","author":"RK Upadhyay","year":"2015","unstructured":"Upadhyay RK. Emerging risk biomarkers in cardiovascular diseases and disorders. J Lipids. 2015;2015:971453.","journal-title":"J Lipids"},{"issue":"13","key":"6127_CR14","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.jacc.2020.07.055","volume":"76","author":"DE Forman","year":"2020","unstructured":"Forman DE, de Lemos JA, Shaw LJ, Reuben DB, Lyubarova R, Peterson ED, Spertus JA, Zieman S, Salive ME, Rich MW. Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council Perspectives. J Am Coll Cardiol. 2020;76(13):1577\u201394.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"6127_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/HCO.0000000000000939","volume":"37","author":"Y Hong","year":"2022","unstructured":"Hong Y, Su WW, Li X. Risk factors of sudden cardiac death in hypertrophic cardiomyopathy. Curr Opin Cardiol. 2022;37(1):15\u201321.","journal-title":"Curr Opin Cardiol"},{"issue":"6","key":"6127_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/clc.23351","volume":"43","author":"H Mills","year":"2020","unstructured":"Mills H, Espersen K, Jurlander R, Iversen K, Bundgaard H, Raja AA. Prevention of sudden cardiac death in hypertrophic cardiomyopathy: Risk assessment using left atrial diameter predicted from left atrial volume. Clin Cardiol. 2020;43(6):581\u20136.","journal-title":"Clin Cardiol"},{"issue":"1","key":"6127_CR17","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3904\/kjim.2022.144","volume":"38","author":"YM Park","year":"2023","unstructured":"Park YM. Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator. Korean J Intern Med. 2023;38(1):7\u201315.","journal-title":"Korean J Intern Med"},{"issue":"24","key":"6127_CR18","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1016\/j.jacc.2020.04.045","volume":"75","author":"EJ Rowin","year":"2020","unstructured":"Rowin EJ, Maron BJ, Carrick RT, Patel PP, Koethe B, Wells S, Maron MS. Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction. J Am Coll Cardiol. 2020;75(24):3033\u201343.","journal-title":"J Am Coll Cardiol"},{"key":"6127_CR19","doi-asserted-by":"publisher","first-page":"1628585","DOI":"10.3389\/fped.2025.1628585","volume":"13","author":"Z Zhen","year":"2025","unstructured":"Zhen Z, Xu Y, Chen X, Na J, Xiao Y, Yuan Y. Developing a risk prediction model for sudden cardiac death in children with hypertrophic cardiomyopathy. Front Pediatr. 2025;13:1628585.","journal-title":"Front Pediatr"},{"issue":"4","key":"6127_CR20","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1080\/10408398.2020.1740644","volume":"61","author":"P Restani","year":"2021","unstructured":"Restani P, Fradera U, Ruf JC, Stockley C, Teissedre PL, Biella S, Colombo F, Lorenzo CD. Grapes and their derivatives in modulation of cognitive decline: a critical review of epidemiological and randomized-controlled trials in humans. Crit Rev Food Sci Nutr. 2021;61(4):566\u201376.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"6127_CR21","doi-asserted-by":"publisher","first-page":"113577","DOI":"10.1016\/j.psychres.2020.113577","volume":"295","author":"D Banerjee","year":"2021","unstructured":"Banerjee D, Kosagisharaf JR, Sathyanarayana Rao TS. The dual pandemic\u2019 of suicide and COVID-19: A biopsychosocial narrative of risks and prevention. Psychiatry Res. 2021;295:113577.","journal-title":"Psychiatry Res"},{"issue":"30","key":"6127_CR22","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1093\/eurheartj\/eht439","volume":"35","author":"C O\u2019Mahony","year":"2014","unstructured":"O\u2019Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, Biagini E, Gimeno JR, Limongelli G, McKenna WJ, Omar RZ, Elliott PM. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J. 2014;35(30):2010\u201320.","journal-title":"Eur Heart J"},{"issue":"9","key":"6127_CR23","doi-asserted-by":"publisher","first-page":"e005968","DOI":"10.1136\/bmjopen-2014-005968","volume":"4","author":"S Nakamura","year":"2014","unstructured":"Nakamura S, Takano H, Matsuda J, Chinen D, Kitamura M, Murai K, Asai K, Yasutake M, Takayama M, Shimizu W. Prognostic values of highly sensitive cardiac troponin T and B-type natriuretic peptide for clinical features in hypertrophic obstructive cardiomyopathy: a cross-sectional study. BMJ Open. 2014;4(9):e005968.","journal-title":"BMJ Open"},{"issue":"23","key":"6127_CR24","doi-asserted-by":"publisher","first-page":"e027618","DOI":"10.1161\/JAHA.122.027618","volume":"11","author":"EL Matthia","year":"2022","unstructured":"Matthia EL, Setteducato ML, Elzeneini M, Vernace N, Salerno M, Kramer CM, Keeley EC. Circulating Biomarkers in Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2022;11(23):e027618.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"6127_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.mayocp.2022.08.010","volume":"98","author":"DR Burczak","year":"2023","unstructured":"Burczak DR, Newman DB, Jaffe AS, Ackerman MJ, Ommen SR, Geske JB. High-Sensitivity Cardiac Troponin T Elevation in Hypertrophic Cardiomyopathy Is Associated With Ventricular Arrhythmias. Mayo Clin Proc. 2023;98(3):410\u20138.","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"6127_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s00246-024-03489-7","volume":"46","author":"W Schmitt","year":"2025","unstructured":"Schmitt W, Diedrich C, Hamza TH, Meyer M, Eissing T, Breitenstein S, Rossano JW, Lipshultz SE. NT-proBNP for Predicting All-Cause Death and Heart Transplant in Children and Adults with Heart Failure. Pediatr Cardiol. 2025;46(3):694\u2013703.","journal-title":"Pediatr Cardiol"},{"key":"6127_CR27","doi-asserted-by":"publisher","first-page":"823076","DOI":"10.3389\/fcvm.2022.823076","volume":"9","author":"Y Deng","year":"2022","unstructured":"Deng Y, Cheng SJ, Hua W, Cai MS, Zhang NX, Niu HX, Chen XH, Gu M, Cai C, Liu X, Huang H, Zhang S. N-Terminal Pro-B-Type Natriuretic Peptide in Risk Stratification of Heart Failure Patients With Implantable Cardioverter-Defibrillator. Front Cardiovasc Med. 2022;9:823076.","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"6127_CR28","doi-asserted-by":"publisher","first-page":"e104","DOI":"10.1016\/j.hlc.2025.03.011","volume":"34","author":"HZ Lo","year":"2025","unstructured":"Lo HZ, Low CE, Yau CE, Teo YH, Teo YN, Li TY, Syn NL, Chai P, Lin W, Yeo TC, Kong WKF, Wong RCC. Sia, Short- and Long-Term Outcomes of Obstructive and Non-Obstructive Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis. Heart Lung Circ. 2025;34(9):e104\u201324.","journal-title":"Heart Lung Circ"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06127-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06127-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:18:19Z","timestamp":1787793499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06127-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6127"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06127-7","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This single-center retrospective study was approved by the Medical Ethics Committee of Jiujiang No.1 People\u2019s Hospital, which served as the central approving ethics committee for the study (Approval No. JJSDYRMY-YXLL-2025110102). The study was conducted in accordance with the Declaration of Helsinki and relevant institutional guidelines. Given the retrospective study design and the use of anonymized clinical data, the requirement for written informed consent was waived by the ethics committee.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"748"}}